ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
14.93
+0.06 (0.40%)
Mar 19, 2026, 3:43 PM EDT - Market open

ADMA Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
146.93197.67-28.24-65.9-71.65
Depreciation & Amortization
8.18.058.337.115.5
Stock-Based Compensation
20.0313.626.195.223.49
Other Adjustments
14.94-82.1232.6412.351.98
Change in Receivables
-108.43-22.58-11.9213.07-15.34
Changes in Inventories
-36.232.67-9.63-38.56-43.19
Changes in Accounts Payable
2.334.153.840.81.36
Changes in Accrued Expenses
5.211.047.537.538.34
Changes in Other Operating Activities
-2.48-3.820.05-1.14-2.85
Operating Cash Flow
50.4118.678.8-59.51-112.37
Operating Cash Flow Growth
-57.53%1248.55%---
Capital Expenditures
-22.58-8.23-4.77-13.91-13.51
Purchases of Intangible Assets
-0.32-0.35-0.21--
Proceeds from Business Divestments
1----
Investing Cash Flow
-21.89-8.58-4.98-13.91-13.51
Short-Term Debt Issued
30----
Short-Term Debt Repaid
-72.5----
Net Short-Term Debt Issued (Repaid)
-42.5----
Long-Term Debt Issued
75-135151.75-
Long-Term Debt Repaid
-33.44-60-158.58-100-
Net Long-Term Debt Issued (Repaid)
41.56-60-23.5851.75-
Issuance of Common Stock
2.987.491.164.82121.14
Repurchase of Common Stock
-41.49-4.97-1.42-2.9-0.06
Net Common Stock Issued (Repurchased)
-38.52.52-0.3161.92121.08
Other Financing Activities
-4.58-0.83-15.09-4.82-0.03
Financing Cash Flow
-44.02-58.3-38.99108.85121.05
Net Cash Flow
-15.5251.8-35.1735.43-4.83
Free Cash Flow
27.82110.454.03-73.42-125.88
Free Cash Flow Growth
-74.81%2641.28%---
FCF Margin
5.45%25.90%1.56%-47.65%-155.52%
Free Cash Flow Per Share
0.110.450.02-0.37-0.90
Levered Free Cash Flow
100.35141.53-46.47-52.31-116
Unlevered Free Cash Flow
108.35222.426.99-77.52-102.73
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q